Recent Updates in the Prevention of Nonalcoholic Fatty Liver Disease
Gene Expression · 2023
DOI: 10.14218/ge.2022.00005s ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene Expression, 2023. Verfasst von Mohamed El-Kassas und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are the leading causes of hepatic fibrosis and liver-related mortality worldwide, despite efficient hepatitis B and C antiviral therapies that have dramatically lowered the disease load. Although significant efforts have been exerted to understand the molecular basis of disease pathogenesis, there are currently few therapeutic alternatives available for NAFLD-associated fibrosis. Thus, NAFLD prevention is critical before the development of disease-related complications. In this context, there is a tremendous substantial global burden on public health systems to actively search for effective preventive and therapeutic targets for NAFLD. In this review, we highlight the current strategies to prevent progression and poor outcomes of NAFLD and to avoid complications associated with disease fibrosis, notably cirrhosis, portal hypertension, and liver cancer. We discuss different nonpharmacological measures, such as lifestyle modifications (weight loss, exercise, healthy diet) and other pharmacological interventions that could prevent NAFLD.
Zitieren
APA
El-Kassas, M., Awad, A., & Méndez-Sánchez, N. (2023). Recent Updates in the Prevention of Nonalcoholic Fatty Liver Disease. Gene Expression. https://doi.org/10.14218/ge.2022.00005s
Vancouver
El-Kassas M, Awad A, Méndez-Sánchez N. Recent Updates in the Prevention of Nonalcoholic Fatty Liver Disease. Gene Expression. 2023. doi:10.14218/ge.2022.00005s
BibTeX
@article{ElKassas2023,
author = {El-Kassas, Mohamed and Awad, Abeer and Méndez-Sánchez, Nahum},
title = {Recent Updates in the Prevention of Nonalcoholic Fatty Liver Disease},
journal = {Gene Expression},
year = {2023},
doi = {10.14218/ge.2022.00005s}
}
EUVIMED